Nuvation Bio Inc. — Director's Dealing 2022

Aug 31, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvation Bio Inc. (NUVB)
CIK: 0001811063
Period of Report: 2022-08-29

Reporting Person: Markel Stacy (Chief People Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-29	Stock Option (Right to Buy)	$2.93	A	450000	Acquired	2032-08-28	Class A Common Stock (450000)	Direct

Footnotes

F1: Option vests as to 25% on the one year anniversary of 8/29/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date